Skip to main content

Table 2 Partial Spearman correlations between betatrophin levels and diabetes/metabolic risk factors

From: Lack of associations between betatrophin/ANGPTL8 level and C-peptide in type 2 diabetic subjects

Variable All T2D Non-diabetics
Betatrophin C-peptide Betatrophin C-peptide Betatrophin C-peptide
Age 0.56 (<0.0001) 0.17 (<0.0001) 0.48 (<0.0001) −0.02 (0.8049) 0.50 (<0.0001) 0.17 (<0.0001)
BMI 0.17 (<0.0001) 0.41 (<0.0001) 0.13 (0.0535) 0.31 (<0.0001) 0.13 (00.0018) 0.44 (<0.0001)
FBG 0.40 (<0.0001) 0.35 (<0.0001) −0.02 (0.8231) 0.09 (0.1965) 0.19 (<0.0001) 0.35 (<0.0001)
Insulin 0.17 (<0.0001) 0.63 (<0.0001) −0.03 (0.7059) 0.39 (<0.0001) 0.11 (0.0121) 0.72 (<0.0001)
Cpeptide 0.26 (<0.0001)   0.07 (0.3366)   0.28 (<0.0001)  
Betatrophin   0.27 (<0.0001)   0.07 (0.3366)   0.28 (<0.0001)
  1. Diabetes: fasting plasma glucose ≥7 mmol/L, under treatment, or self-reported of previously diagnosed T2D; waist/hip ratio. Duration of diabetes was calculated for subjects with diabetes. Partial Spearman correlation coefficients were adjusted for age, gender, and ethnicity
  2. BMI body mass index, FBG fasting blood glucose